BELL vs. IUG, NCYT, POLX, IHC, AVO, MHC, RUA, SUN, DEMG, and SN
Should you be buying Belluscura stock or one of its competitors? The main competitors of Belluscura include Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), MyHealthChecked (MHC), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), Deltex Medical Group (DEMG), and Smith & Nephew (SN). These companies are all part of the "medical devices" industry.
Belluscura vs.
Belluscura (LON:BELL) and Intelligent Ultrasound Group (LON:IUG) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, earnings, community ranking, dividends, analyst recommendations and institutional ownership.
Belluscura has a net margin of 0.00% compared to Intelligent Ultrasound Group's net margin of -33.78%. Intelligent Ultrasound Group's return on equity of -36.19% beat Belluscura's return on equity.
Belluscura and Intelligent Ultrasound Group both received 0 outperform votes by MarketBeat users.
Intelligent Ultrasound Group has higher revenue and earnings than Belluscura. Intelligent Ultrasound Group is trading at a lower price-to-earnings ratio than Belluscura, indicating that it is currently the more affordable of the two stocks.
In the previous week, Intelligent Ultrasound Group had 1 more articles in the media than Belluscura. MarketBeat recorded 1 mentions for Intelligent Ultrasound Group and 0 mentions for Belluscura. Belluscura's average media sentiment score of 0.00 equaled Intelligent Ultrasound Group'saverage media sentiment score.
6.3% of Belluscura shares are held by institutional investors. Comparatively, 75.5% of Intelligent Ultrasound Group shares are held by institutional investors. 56.3% of Belluscura shares are held by company insiders. Comparatively, 12.8% of Intelligent Ultrasound Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Belluscura has a beta of 1.05, meaning that its stock price is 5% more volatile than the S&P 500. Comparatively, Intelligent Ultrasound Group has a beta of 0.38, meaning that its stock price is 62% less volatile than the S&P 500.
Summary
Intelligent Ultrasound Group beats Belluscura on 7 of the 12 factors compared between the two stocks.
Get Belluscura News Delivered to You Automatically
Sign up to receive the latest news and ratings for BELL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Belluscura Competitors List
Related Companies and Tools
This page (LON:BELL) was last updated on 1/22/2025 by MarketBeat.com Staff
Free BELL Stock Alerts